Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 1990:39 Suppl 1:32-8.
doi: 10.2165/00003495-199000391-00006.

Comparative cardiovascular effects of drugs used for hypertension

Affiliations
Review

Comparative cardiovascular effects of drugs used for hypertension

M Burnier et al. Drugs. 1990.

Abstract

Currently 4 classes of antihypertensive drugs - diuretics, beta-blockers, calcium channel blockers and angiotensin-converting enzyme (ACE) inhibitors - are most commonly used to treat hypertensive patients. Each class of drug has a distinctive cardiovascular pharmacodynamic profile and even within classes there exist agents with slightly different properties. The effects of the various drug classes on the heart and peripheral circulation, on the kidney and electrolyte metabolism, on the brain and on the renin-angiotensin system are now reasonably well described. Knowledge and understanding of these different cardiovascular effects are extremely important in order to adapt treatment to the needs of an individual patient. Furthermore, when combination therapy becomes necessary, the different cardiovascular aspects of the various drugs can be used to enhance antihypertensive efficacy and to attenuate adverse effects of separate compounds.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Br J Clin Pharmacol. 1979;7 Suppl 2:219S-225S - PubMed
    1. Hypertension. 1988 Mar;11(3 Pt 2):II42-4 - PubMed
    1. Eur Heart J. 1983 Jan;4 Suppl A:189-97 - PubMed
    1. Drugs. 1985;30 Suppl 1:6-12 - PubMed
    1. Hypertension. 1988 Mar;11(3 Pt 2):II21-9 - PubMed

MeSH terms

Substances

LinkOut - more resources